CMBS vs. life company loans: choosing the right permanent execution

When it comes to permanent financing on stabilized commercial real estate, two of the most common execution paths are CMBS conduit loans and life company (insurance company) loans. Both offer fixed-rate, non-recourse financing with 5- to 10-year terms — but the differences beneath the surface are significant and can materially impact your cost of capital and operational flexibility over the life of the loan.

CMBS loans are originated by conduit lenders, pooled with other loans, and securitized into bonds sold to investors. The defining characteristic of CMBS is standardization: once the loan is closed and securitized, the servicer is bound by the pooling and servicing agreement (PSA), which governs what can and cannot be done with the loan. This rigidity is both the primary advantage and disadvantage of CMBS.

The advantage is that CMBS loans typically offer higher leverage — up to 75% LTV on some asset types — and are more accommodating on properties with lower DSCRs. They also tend to have lower rates than life companies on assets that are slightly below institutional quality. CMBS is non-recourse with standard carve-out guarantees, and assumable by future buyers subject to lender approval.

The disadvantage is inflexibility. Want to release collateral for a sale? The PSA governs it. Need to modify the loan for a tenant buildout? The special servicer has to approve. Want to pay down early? Defeasance — the process of buying bonds to replace the loan's cash flow — can be expensive and is required for most of the loan term. For sponsors who value operational flexibility, CMBS rigidity can be frustrating.

Life company loans, by contrast, are held on the insurance company's balance sheet. This means the lender retains discretion over the loan throughout its life — there's a human being you can call to discuss a modification, a release, or a payoff. Life company loans are typically lower leverage (65-70% LTV max), but offer more flexible prepayment (often yield maintenance with more negotiable terms or even open periods in the final year), and greater willingness to accommodate business plan needs during the loan term.

Life companies also tend to be more selective about asset quality — they prefer institutional-grade properties with strong sponsors and credit tenants. But for assets that qualify, the relationship-driven nature of life company lending can be a significant advantage. Rate-wise, life company loans can be competitive with or better than CMBS on top-quality assets.

Our guidance: choose CMBS when you need maximum proceeds, have a stabilized asset, and value rate and leverage over flexibility. Choose life company when you have a quality asset, want a lender relationship with discretion, and anticipate needing flexibility during the loan term. And in every case, evaluate both options simultaneously — the right choice often depends on the specific terms each source is willing to offer on your particular transaction.